Published in Clinical Trials Week, January 25th, 2010
Commenting on the website, Joe Bishop, Chief Executive Officer said, "The website will be an important tool in support of our plans for the global market launch of the SoloPath TransFemoral Endovascular Access Catheter and the Pathway Urology products." The Controlled Deployment Technology Platform The SoloPath TransFemoral Endovascular Access Catheter uses Onset's Controlled Deployment Technology ("CDT") in a new and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.